The World Health Organization will monitor the side effects of HIV meds around the world to see if they vary according to different treatment strategies. The announcement, made at the HIV Implementer’s meeting in Kigali, Rwanda, follows a WHO decision to recommend a lower dose of d4T (known in the U.S. as Zerit).